An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched today, with Union Defence Minister Rajnath Singh distributing around 10,000 doses to some hospitals in the national capital.
The drug, called 2-deoxy-D-glucose or 2-DG, was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy’s Laboratories. Drugs Controller General of India (DCGI), the country’s top drug regulator, has approved the medicine for emergency use.

The medicine was found to be safe for COVID-19 patients in phase 2 trials, conducted between May and October last year. It was found to be effective in cutting short the hospital stays of Covid patients and reducing their supplemental oxygen dependence.

A kind of pseudo glucose molecule in the drug stops the virus in its tracks, the defence body says.

The medicine comes in powder form and can be taken with water.

2-DG is one of the few medicines across the world that have been designed specifically to treat COVID-19, which, as of now, has no cure. Doctors use several experimental drugs and procedures, including Remdevisir, Ivermectin, plasma therapy and some steroids, to treat the deadly infection.

Curtesy : NDTV NEWS

Compiled_CVC_plan-converted

Order_for_State_Committee_on_Oxygen (1)

4,31,285 beneficiaries of the age group 18-44 years received their first dose of COVID vaccine in the last 24 hours and cumulatively 34,80,618 across 30 States/UTs since the start of phase-3 of vaccination drive. Table below shows the cumulative vaccine doses administered to 18-44 years age group till now.
India’s cumulative recoveries stand at 1,97,34,823 today. The National Recovery Rate is 83.26%.
The National Mortality Rate currently stands at 1.09%.
For Details : https://pib.gov.in/PressReleasePage.aspx?PRID=1718217

The solution from Swadhin involves creating mass awareness through a combination Social Media and with our Health warriors The information shared is in strict compliance with Government protocols and available in the local languages. The contents focus on the following areas:
• Measures on social distancing
• Hand washing hygiene & procedure
• Understanding symptoms of COVID-19 and taking adequate measures
• Awareness building to seek doctor’s consultation
• Addressing phobia around quarantines and self isolation
• Address mental distress & anxiety
• Questionnaire for self assessment based on symptomatic behavior
• Questionnaire to assess awareness level
In order to drive the mass awareness and counseling, Swadhin has developed an initiative to train frontline health workers on a Train-The-Trainer approach. These Trainers will in turn train area volunteers/ representatives. These trained members will be deployed in the identified areas for awareness, counseling and identification of high risk members.

• The Doctor will be able to view patient details before, during and after the call. This includes demographics, vitals and clinical information such as prescriptions and results.
• The doctor can enter the prescription in the webinar and this can be viewed by the patient.